logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9358279 B1

PDFFull Text
Date of Patent:
Jun. 07, 2016

Filed:

Oct. 28, 2014

Immunogenic composition

Applicant:

Glaxosmithkline Biologicals S.a., Rixensart, BE;

Inventors:

Ralph Leon Biemans, Rixensart, BE;

Dominique Boutriau, Rixensart, BE;

Carine Capiau, Rixensart, BE;

Philippe Denoel, Rixensart, BE;

Pierre Duvivier, Rixensart, BE;

Jan Poolman, Rixensart, BE;

Assignee:

GLAXOSMITHKLINE BIOLOGICALS S.A., Rixensart, BE;

Attorney:

Barbara J. Carter

Primary Examiner:

Albert Navarro

Int. Cl.
CPC ...
A61K 39/385 (2006.01); A61K 39/102 (2006.01); A61K 39/095 (2006.01); A61K 39/116 (2006.01); C07H 3/00 (2006.01); A61K 39/05 (2006.01); A61K 39/08 (2006.01); A61K 39/09 (2006.01); A61K 39/02 (2006.01); A61K 39/29 (2006.01); A61K 39/00 (2006.01); A61K 39/12 (2006.01);
U.S. Cl.
CPC ...
A61K 39/102 (2013.01); A61K 39/0017 (2013.01); A61K 39/0018 (2013.01); A61K 39/05 (2013.01); A61K 39/08 (2013.01); A61K 39/092 (2013.01); A61K 39/095 (2013.01); A61K 39/099 (2013.01); A61K 39/116 (2013.01); A61K 39/292 (2013.01); C07H 3/00 (2013.01); A61K 39/12 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55 (2013.01); A61K 2039/6037 (2013.01); A61K 2039/627 (2013.01); A61K 2039/70 (2013.01); C12N 2730/10134 (2013.01); C12N 2770/32634 (2013.01);
Abstract

The present application discloses an immunogenic composition comprising a Hib saccharide conjugate, at least one additional bacterial, for example, saccharide conjugate(s), and a further antigen selected from the group consisting of whole cell pertussis and hepatitis B surface antigen, wherein the saccharide dose of the Hib saccharide conjugate is less than 5 μg.

Find Patent Forward Citations

Biemans, Ralph. (2016). Immunogenic composition (U.S. Patent No. 9358279). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9358279

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…